Full Name
Dr. Joris Vandeputte
Job Title
Past President IABS
Speaker Bio
Joris Vandeputte was elected President of IABS (International Alliance for International Alliance for Biological Standardization Biological Standardization) in June 2016. He is founding member of IABS-EU the European affiliate of IABS. IABS-EU implements the objectives of IABS at European level. IABS-EU is partner of the EU IMI (Innovative Medicines Initiative) projects ZAPI and VAC2VAC (www.IMI.eu, www.zapi-imi.eu, www.vac2vac.eu.
IABS hold its founding congress in Lyon in 1955. It is the global independent platform, interface, where stake-holders meet for exchange of science and issues related to vaccines, cell and gene therapy and human Biotherapeutics. IABS stimulates consensus building which might eventually be translated in regulatory frameworks and advises to decision makers.
Joris Vandeputte is also founder and president of TRIVAROP, a public affairs consultancy advising companies and associations in the area of global health care. Joris has more than 40 years industry and
international organisation’s experience in vaccines, conceiving and developing vaccine policies at global level and towards developing countries in particular. Working with European institutions and policymakers on innovation, health and development is his main activity.
IABS hold its founding congress in Lyon in 1955. It is the global independent platform, interface, where stake-holders meet for exchange of science and issues related to vaccines, cell and gene therapy and human Biotherapeutics. IABS stimulates consensus building which might eventually be translated in regulatory frameworks and advises to decision makers.
Joris Vandeputte is also founder and president of TRIVAROP, a public affairs consultancy advising companies and associations in the area of global health care. Joris has more than 40 years industry and
international organisation’s experience in vaccines, conceiving and developing vaccine policies at global level and towards developing countries in particular. Working with European institutions and policymakers on innovation, health and development is his main activity.
